A carregar...
Targeted Therapy in Metastatic Breast Cancer: The HER2/neu Oncogene
SUMMARY: Besides surgery, radiation, chemotherapy, and endocrine treatment, immunotherapy has become an established part of systemic therapy in treating metastatic breast cancer. One of the most interesting targets for the design of anticancer therapeutics is the HER2/ErbB2 receptor which is overexp...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger GmbH
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2931093/ https://ncbi.nlm.nih.gov/pubmed/20847829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000285714 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|